These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24597695)

  • 61. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases.
    Bala S; Petrasek J; Mundkur S; Catalano D; Levin I; Ward J; Alao H; Kodys K; Szabo G
    Hepatology; 2012 Nov; 56(5):1946-57. PubMed ID: 22684891
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.
    Liu N; Jiao T; Huang Y; Liu W; Li Z; Ye X
    J Virol; 2015 Mar; 89(5):2739-49. PubMed ID: 25540364
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liver-specific microRNAs as biomarkers of nanomaterial-induced liver damage.
    Nagano T; Higashisaka K; Kunieda A; Iwahara Y; Tanaka K; Nagano K; Abe Y; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Yoshioka Y; Tsutsumi Y
    Nanotechnology; 2013 Oct; 24(40):405102. PubMed ID: 24029385
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
    Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
    J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Short-term entecavir therapy of chronic severe hepatitis B.
    Chen J; Han JH; Liu C; Yu RH; Li FZ; Li QF; Gong GZ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):261-6. PubMed ID: 19502165
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47
    Li M; He Y; Zhou Z; Ramirez T; Gao Y; Gao Y; Ross RA; Cao H; Cai Y; Xu M; Feng D; Zhang P; Liangpunsakul S; Gao B
    Gut; 2017 Apr; 66(4):705-715. PubMed ID: 27679493
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury.
    Yamaura Y; Tatsumi N; Takagi S; Tokumitsu S; Fukami T; Tajiri K; Minemura M; Yokoi T; Nakajima M
    Clin Biochem; 2017 Dec; 50(18):1034-1039. PubMed ID: 28823616
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.
    Zhang X; Zhang Z; Dai F; Shi B; Chen L; Zhang X; Zang G; Zhang J; Chen X; Qian F; Hu Y; Yuan Z
    PLoS One; 2014; 9(3):e92112. PubMed ID: 24643113
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus.
    Kiesslich D; Crispim MA; Santos C; Ferreira Fde L; Fraiji NA; Komninakis SV; Diaz RS
    J Infect Dis; 2009 Jun; 199(11):1608-11. PubMed ID: 19388852
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Hsu CA; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Hepatology; 2013 Feb; 57(2):441-50. PubMed ID: 22941922
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
    Kondo Y; Ueno Y; Kobayashi K; Kakazu E; Shiina M; Inoue J; Tamai K; Wakui Y; Tanaka Y; Ninomiya M; Obara N; Fukushima K; Ishii M; Kobayashi T; Niitsuma H; Kon S; Shimosegawa T
    J Infect Dis; 2010 Jul; 202(2):202-13. PubMed ID: 20533879
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Evaluation of miR-122 level in the plasma of chronically HCV infected patients].
    Gholami M; Ravanshad M; Alavian SM; Baesi K; Moallemi S
    Mol Biol (Mosk); 2016; 50(2):279-83. PubMed ID: 27239848
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
    Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.
    Watanabe K; Takahashi T; Takahashi S; Okoshi S; Ichida T; Aoyagi Y
    J Gastroenterol Hepatol; 2005 Mar; 20(3):441-9. PubMed ID: 15740490
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessment of Preclinical Liver and Skeletal Muscle Biomarkers Following Clofibrate Administration in Wistar Rats.
    Maliver P; Festag M; Bennecke M; Christen F; Bánfai B; Lenz B; Winter M
    Toxicol Pathol; 2017 Jun; 45(4):506-525. PubMed ID: 28485676
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Relation of serological markers of hepatitis B virus and alanine transaminase to hepatic tissue pathology in patients with chronic hepatitis B].
    Yang XY; Wen FY; Wu JL; Zhou HJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):892-3. PubMed ID: 16793626
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Naturally occurring deletions/insertions in HBV core promoter tend to decrease in hepatitis B e antigen-positive chronic hepatitis B patients during antiviral therapy.
    Peng Y; Liu B; Hou J; Sun J; Hao R; Xiang K; Yan L; Zhang J; Zhuang H; Li T
    Antivir Ther; 2015; 20(6):623-32. PubMed ID: 25838313
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum microRNA‑122 for assessment of acute liver injury in patients with extensive skeletal muscle damage.
    Zhang Y; Ong CM; Lynch K; Waksman J; Wu AHB
    Lab Med; 2024 Sep; 55(5):609-614. PubMed ID: 38578664
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Performance Evaluation of Liver and Skeletal Muscle-Specific miRNAs in Rat Plasma to Detect Drug-Induced Injury.
    Bailey WJ; Barnum JE; Erdos Z; LaFranco-Scheuch L; Lane P; Vlasakova K; Sistare FD; Glaab WE
    Toxicol Sci; 2019 Mar; 168(1):110-125. PubMed ID: 30496518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.